Back    Zoom +    Zoom -
WUXI XDC Plummets 6%+; Shareholder STA Pharmaceutical Cuts Stake
Recommend
6
Positive
9
Negative
6
STA Pharmaceutical Hong Kong Investment, the shareholder of WUXI XDC (02268.HK), placed 37.8 million shares of the company at $30.855-31.515 per share, a discount of 4.5-6.5% to last Friday's closing price, Bloomberg cited a sales filing. The lock-up period is 90 days. Morgan Stanley is the sole bookrunner.

WUXI XDC, with 50 million shares at $31.09 per share in block trade, opened 1.52% lower, bottoming at $28.6 this morning (13th). It last posted at $30.9, down 6.36%, with deals driven by share placing, which increased to 52.4255 million shares, involving $1.629 billion.

Related NewsBOCI Hikes WUXI BIO (02269.HK) TP to $19; Rating Hold

AAStocks Financial News